中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 36 Issue 4
Apr.  2020
Turn off MathJax
Article Contents

Effect of Aldo-keto reductase family 1 member B10 gene silencing on the proliferation and apoptosis of hepatocellular carcinoma cells

DOI: 10.3969/j.issn.1001-5256.2020.04.018
Research funding:

 

  • Received Date: 2019-11-06
  • Published Date: 2020-04-20
  • Objective To investigate the biological functions and related pathological mechanisms of Aldo-keto reductase family 1 member B10(AKR1 B10) in hepatocellular carcinoma(HCC).Methods The COLE database was used to analyze the mRNA expression of AKR1 B10 in normal liver cells and HCC cell lines.The UALCAN and Oncomine databases were used to analyze the mRNA expression of AKR1 B10 in HCC tissue and adjacent tissue.Western blot was used to investigate the difference in the protein expression of AKR1 B10 between HCC tissue and adjacent tissue.AKR1 B10 in HepG2 and Huh7 cells was knocked down by lentivirus,and the cells were divided into control group and AKR1 B10 knockdown group(which was further divided into shAKR1 B10 1# group and shAKR1 B10 2# group).AnnexinVAPC/PI double staining,colony formation assay,and the method of subcutaneous xenograft tumor were used to observe the apoptosis of HCC cells,colony formation,and the change in the volume of subcutaneous xenograft tumor after AKR1 B10 knockdown.The peroxide-sensitive fluorescent probe DCFH-DA and Western blot were used to measure the changes in ROS and related proteins,such as pATMser1981,γ-H2 AX,c-Caspase-3,and c-RARP in HCC cells.A one-way analysis of variance was used for comparison of continuous data between multiple groups,and the SNK-q test was used for further comparison between two groups.Results The CCLE database showed that the mRNA expression of AKR1 B10 in HCC cells was significantly higher than that in normal liver cells) the Oncomine database suggested that the mRNA expression of AKR1 B10 in HCC tissue was more than 10 times that in adjacent tissue) the UALCAN database showed that the AKR1 B10 gene was highly expressed in HCC tissue.For the six patients in this study,the expression of AKR1 B10 in HCC tissue was significantly higher than that in adjacent tissue.Compared with the control group,the AKR1 B10 knockdown group had a significant reduction in the colony formation ability of HCC cells(P <0.001) and a significant increase in apoptosis rate(P <0.001).Compared with the control group,the AKR1 B10 knockdown group had significant increases in ROS,the markers for DNA damage p-ATMser1981 and γ-H2 AX,and the indices for cell apoptosis c-Caspase-3 and c-RARP.In the BALB-c/Nude mouse model,compared with the control group,the AKR1 B10 knockdown group had a significant reduction in tumor volume since day 13 after allograft transplantation(P <0.05).Conclusion AKR1 B10 may be an effective therapeutic target for the treatment of HCC.

     

  • loading
  • [1] MA J,LUO DX,HUANG C,et al. AKR1B10 overexpression in breast cancer:Association with tumor size,lymph node metastasis and patient survival and its potential as a novel serum marker[J]. Int J Cancer,2012,131(6):e862-e871.
    [2] SATO S,GENDA T,ICHIDA T,et al. Impact of aldo-keto reductase family 1 member B10 on the risk of hepatitis C virusrelated hepatocellular carcinoma[J]. J Gastroenterol Hepatol,2016,31(7):1315-1322.
    [3] CHUNG YT,MATKOWSKYJ KA,LI H,et al. Overexpression and oncogenic function of aldo-keto reductase family 1B10(AKR1B10)in pancreatic carcinoma[J]. Mod Pathol,2012,25(5):758-766.
    [4] FUKUMOTO S,YAMAUCHI N,MORIGUCHI H,et al. Overexpression of the aldo-keto reductase family protein AKR1B10is highly correlated with smokers’non-small cell lung carcinomas[J]. Clin Cancer Res,2005,11(5):1776-1785.
    [5] CHEN WD,ZHANG Y. Regulation of aldo-keto reductases in human diseases[J]. Front Pharmacol,2012,3:35.
    [6] GIANNINI EG,MARENCO S,BRUZZONE L,et al. Hepatocellular carcinoma in patients without cirrhosis in Italy[J]. Dig Liver Dis,2013,45(2):164-169.
    [7] KULIK LM,CHOKECHANACHAISAKUL A. Evaluation and management of hepatocellular carcinoma[J]. Clin Liver Dis,2015,19(1):23-43.
    [8] GRANJA S,PINHEIRO C,REIS RM,et al. Glucose addiction in cancer therapy:Advances and drawbacks[J]. Curr Drug Metab,2015,16(3):221-242.
    [9] GANAPATHY-KANNIAPPAN S,GESCHWIND JF. Tumor glycolysis as a target for cancer therapy:Progress and prospects[J]. Mol Cancer,2013,12:152.
    [10] PANIERI E,SANTORO MM. ROS homeostasis and metabolism:A dangerous liason in cancer cells[J]. Cell Death Dis,2016,7(6):e2253.
    [11] LEE JH,PAULL TT. Activation and regulation of ATM kinase activity in response to DNA double-strand breaks[J]. Oncogene,2007,26(56):7741-7748.
    [12] REDON CE,DICKEY JS,BONNER WM,et al.γ-H2AX as a biomarker of DNA damage induced by ionizing radiation in human peripheral blood lymphocytes and artificial skin[J]. Adv Space Res,2009,43(8):1171-1178.
    [13] TONG L,CHUANG CC,WU S,et al. Reactive oxygen species in redox cancer therapy[J]. Cancer Lett,2015,367(1):18-25.
    [14] WANG Z,LI S,CAO Y,et al. Oxidative stress and carbonyl lesions in ulcerative colitis and associated colorectal cancer[J]. Oxid Med Cell Longev,2016,2016:9875298.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (1049) PDF downloads(210) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return